209 related articles for article (PubMed ID: 11721619)
21. Site-specific integration of a transgene mediated by a hybrid adenovirus/adeno-associated virus vector using the Cre/loxP-expression-switching system.
Ueno T; Matsumura H; Tanaka K; Iwasaki T; Ueno M; Fujinaga K; Asada K; Kato I
Biochem Biophys Res Commun; 2000 Jul; 273(2):473-8. PubMed ID: 10873630
[TBL] [Abstract][Full Text] [Related]
22. Efficient expression of the vascular endothelial growth factor gene in vitro and in vivo, using an adeno-associated virus vector.
Byun J; Heard JM; Huh JE; Park SJ; Jung EA; Jeong JO; Gwon HC; Kim DK
J Mol Cell Cardiol; 2001 Feb; 33(2):295-305. PubMed ID: 11162134
[TBL] [Abstract][Full Text] [Related]
23. An improved system for packaging recombinant adeno-associated virus vectors capable of in vivo transduction.
Flotte TR; Barraza-Ortiz X; Solow R; Afione SA; Carter BJ; Guggino WB
Gene Ther; 1995 Jan; 2(1):29-37. PubMed ID: 7712331
[TBL] [Abstract][Full Text] [Related]
24. Construction and packaging of herpes simplex virus/adeno-associated virus (HSV/AAV) Hybrid amplicon vectors.
Saydam O; Glauser DL; Fraefel C
Cold Spring Harb Protoc; 2012 Mar; 2012(3):352-6. PubMed ID: 22383640
[TBL] [Abstract][Full Text] [Related]
25. Current development of adeno-associated viral vectors.
Romano G
Drug News Perspect; 2005 Jun; 18(5):311-6. PubMed ID: 16193103
[TBL] [Abstract][Full Text] [Related]
26. Purification of recombinant adeno-associated virus vectors by column chromatography and its performance in vivo.
Gao G; Qu G; Burnham MS; Huang J; Chirmule N; Joshi B; Yu QC; Marsh JA; Conceicao CM; Wilson JM
Hum Gene Ther; 2000 Oct; 11(15):2079-91. PubMed ID: 11044910
[TBL] [Abstract][Full Text] [Related]
27. Site-specific integration of functional transgenes into the human genome by adeno/AAV hybrid vectors.
Recchia A; Perani L; Sartori D; Olgiati C; Mavilio F
Mol Ther; 2004 Oct; 10(4):660-70. PubMed ID: 15451450
[TBL] [Abstract][Full Text] [Related]
28. Transfection-free and scalable recombinant AAV vector production using HSV/AAV hybrids.
Booth MJ; Mistry A; Li X; Thrasher A; Coffin RS
Gene Ther; 2004 May; 11(10):829-37. PubMed ID: 14985784
[TBL] [Abstract][Full Text] [Related]
29. Improved cardiac gene transfer by transcriptional and transductional targeting of adeno-associated viral vectors.
Müller OJ; Leuchs B; Pleger ST; Grimm D; Franz WM; Katus HA; Kleinschmidt JA
Cardiovasc Res; 2006 Apr; 70(1):70-8. PubMed ID: 16448634
[TBL] [Abstract][Full Text] [Related]
30. Basic biology of adeno-associated virus (AAV) vectors used in gene therapy.
Balakrishnan B; Jayandharan GR
Curr Gene Ther; 2014; 14(2):86-100. PubMed ID: 24588706
[TBL] [Abstract][Full Text] [Related]
31. Adeno-associated viral vector-mediated immune responses: Understanding barriers to gene delivery.
Nidetz NF; McGee MC; Tse LV; Li C; Cong L; Li Y; Huang W
Pharmacol Ther; 2020 Mar; 207():107453. PubMed ID: 31836454
[TBL] [Abstract][Full Text] [Related]
32. Adeno-associated viral vectors: background and technical aspects.
Snoeck HW; Tao W; Klotman ME
Exp Nephrol; 1997; 5(6):514-20. PubMed ID: 9438181
[TBL] [Abstract][Full Text] [Related]
33. Adeno-associated virus vectors for gene therapy.
Flotte TR; Carter BJ
Gene Ther; 1995 Aug; 2(6):357-62. PubMed ID: 7584109
[TBL] [Abstract][Full Text] [Related]
34. AAV as a viral vector for human gene therapy. Generation of recombinant virus.
Rolling F; Samulski RJ
Mol Biotechnol; 1995 Feb; 3(1):9-15. PubMed ID: 7606507
[TBL] [Abstract][Full Text] [Related]
35. Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors.
Snyder RO; Miao CH; Patijn GA; Spratt SK; Danos O; Nagy D; Gown AM; Winther B; Meuse L; Cohen LK; Thompson AR; Kay MA
Nat Genet; 1997 Jul; 16(3):270-6. PubMed ID: 9207793
[TBL] [Abstract][Full Text] [Related]
36. Improved adeno-associated virus vector production with transfection of a single helper adenovirus gene, E4orf6.
Allen JM; Halbert CL; Miller AD
Mol Ther; 2000 Jan; 1(1):88-95. PubMed ID: 10933916
[TBL] [Abstract][Full Text] [Related]
37. Production of recombinant adeno-associated viral vectors for in vitro and in vivo use.
Choi VW; Asokan A; Haberman RA; Samulski RJ
Curr Protoc Mol Biol; 2007 Apr; Chapter 16():Unit 16.25. PubMed ID: 18265393
[TBL] [Abstract][Full Text] [Related]
38. HSV/AAV hybrid amplicon vectors extend transgene expression in human glioma cells.
Johnston KM; Jacoby D; Pechan PA; Fraefel C; Borghesani P; Schuback D; Dunn RJ; Smith FI; Breakefield XO
Hum Gene Ther; 1997 Feb; 8(3):359-70. PubMed ID: 9048203
[TBL] [Abstract][Full Text] [Related]
39. Gene delivery to the mammalian heart using AAV vectors.
Chu D; Thistlethwaite PA; Sullivan CC; Grifman MS; Weitzman MD
Methods Mol Biol; 2004; 246():213-24. PubMed ID: 14970595
[TBL] [Abstract][Full Text] [Related]
40. Adeno-associated viral vectors for gene transfer and gene therapy.
Büeler H
Biol Chem; 1999 Jun; 380(6):613-22. PubMed ID: 10430026
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
